4.8 Article

Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells

Journal

ELIFE
Volume 7, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.39494

Keywords

-

Categories

Funding

  1. Thrasher Research Fund
  2. National Institute of Allergy and Infectious Diseases [K99 AI135031, R01 AI125249, U19 AI116484]
  3. Walter V. and Idun Berry Foundation
  4. Institute for Immunity, Transplantation and Infection, Stanford University Young Investigator Award
  5. National Natural Science Foundation of China [81788104, 31770990]
  6. Chinese Academy of Sciences Strategic Priority Research Program [XDPB03]
  7. Howard Hughes Medical Institute
  8. U.S. Department of Veterans Affairs [GRH0022]

Ask authors/readers for more resources

Rotaviruses (RVs), a leading cause of severe diarrhea in young children and many mammalian species, have evolved multiple strategies to counteract the host innate immunity, specifically interferon (IFN) signaling through RV non-structural protein 1 (NSP1). However, whether RV structural components also subvert antiviral response remains under-studied. Here, we found that MAVS, critical for the host RNA sensing pathway upstream of IFN induction, is degraded by the RV RNA methyl- and guanylyl-transferase (VP3) in a host-range-restricted manner. Mechanistically, VP3 localizes to the mitochondria and mediates the phosphorylation of a previously unidentified SPLTSS motif within the MAVS proline-rich region, leading to its proteasomal degradation and blockade of IFN-lambda production in RV-infected intestinal epithelial cells. Importantly, VP3 inhibition of MAVS activity contributes to enhanced RV replication and to viral pathogenesis in vivo. Collectively, our findings establish RV VP3 as a viral antagonist of MAVS function in mammals and uncover a novel pathogen-mediated inhibitory mechanism of MAVS signaling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available